Paul A. VanderLaan

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

Matthew J. Niederst, Lecia V. Sequist, John T. Poirier et al. · Nature Communications · 2015 · 619 citations · Full text

Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancers

Deepa Rangachari, Norihiro Yamaguchi, Paul A. VanderLaan et al. · Lung Cancer · 2015 · 509 citations · Full text

The 2023 Bethesda System for Reporting Thyroid Cytopathology

Syed Z. Ali, Zubair Baloch, Béatrix Cochand‐Priollet et al. · Thyroid · 2023 · 291 citations

Diagnosis, Pathology, Thyroid Cytopathology +20

Clinical Outcome for Atypia of Undetermined Significance in Thyroid Fine-Needle Aspirations

Paul A. VanderLaan, Ellen Marqusee, Jeffrey F. Krane · American Journal of Clinical Pathology · 2011 · 216 citations · Full text

Surgical Oncology, Repeated Fna, Diagnosis +19

Mutations in TP53 , PIK3CA , PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomes

Paul A. VanderLaan, Deepa Rangachari, Susan M. Mockus et al. · Lung Cancer · 2017 · 207 citations · Full text

Lung Cancers, Oncology, Medicine +11